MktsMarkets

Contineum Therapeutics, Inc.
NASDAQ: CTNMKey statistics
CTNM News
Stories mentioning CTNM from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | ||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | ||||||||
| Research & Development | 11,648 | 12,755 | 10,992 | 14,063 | 13,712 | 13,015 | 9,728 | 7,901 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 16,904 | 17,115 | 14,932 | 17,902 | 18,110 | 17,046 | 12,974 | 10,944 |
| Operating Income (Loss) | (16,904) | (17,115) | (14,932) | (17,902) | (18,110) | (17,046) | (12,974) | (10,944) |
| Interest Income | 2,505 | 2,010 | 1,957 | 2,029 | 2,250 | 2,527 | 2,741 | 2,001 |
| Interest Expense | ||||||||
| Other Expense | (57.00) | (51.00) | 183.00 | (167.00) | (130.00) | (46.00) | (34.00) | (77.00) |
| Pretax Income | (14,565) | (10,267) | (9,009) | |||||
| Tax Provision | 0.00 | 0.00 | 0.00 | |||||
| Net Income (Loss) | (14,456) | (15,156) | (12,792) | (16,040) | (15,990) | (14,565) | (10,267) | (9,009) |
| Earnings Per Share (Basic) | (0.39) | (0.55) | (0.45) | (0.62) | (0.62) | (0.75) | (0.40) | (0.39) |
| Earnings Per Share (Diluted) | (0.39) | (0.62) | (0.75) | (0.40) | (0.39) | |||
| Weighted Average Shares Outstanding (Basic) | 37,339 | 27,701 | 28,116 | 25,896 | 25,869 | 19,353 | 25,730 | 23,356 |
| Weighted Average Shares Outstanding (Diluted) | 37,339 | 25,869 | 19,353 | 25,730 | 23,356 | |||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CTNM
Contineum Therapeutics, Inc. (NASDAQ: CTNM) is a stock listed on the Nasdaq Stock Market under the ticker symbol CTNM. It last traded at $10.30 (Nov 9, 2026, 4:00 PM ET), up 8.2% on the day. That gives Contineum Therapeutics a market capitalisation of $373.8M.
Over the past 52 weeks CTNM has traded between $6.72 and $17.79.
For the quarter ended Mar 31, 2026 it reported a net loss of $14.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$14.5M |
| Dec 31, 2025 | — | -$15.2M |
| Sep 30, 2025 | — | -$12.8M |
| Jun 30, 2025 | — | -$16.0M |
From Contineum Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…